The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

AEterna Zentaris Inc

Nasdaq: AEZS
Last

(U.S.) $2.70

Today's change-0.05 -1.82%
Updated January 20 4:00 PM -5GMT. Delayed by at least 15 minutes.
 

AEterna Zentaris Inc

Nasdaq: AEZS
Last

(U.S.) $2.70

Today's change-0.05 -1.82%
Updated January 20 4:00 PM -5GMT. Delayed by at least 15 minutes.

AEterna Zentaris Inc down (U.S.)$0.05

AEterna Zentaris Inc closed sharply lower Friday, dropping (U.S.)$0.05 or 1.82% to (U.S.)$2.70. Over the last five days, shares have gained 5.88%, but are down 10.30% for the last 52 weeks, lagging the 22.16% return in the S&P 500.

Key company metrics

  • Open(U.S.) $2.80
  • Previous close(U.S.) $2.75
  • High(U.S.) $2.80
  • Low(U.S.) $2.60
  • Bid / Ask(U.S.) $0.00 / (U.S.) $7.00
  • YTD % change-25.00%
  • Volume127,349
  • Average volume (10-day)516,955
  • Average volume (1-month)368,259
  • Average volume (3-month)378,759
  • 52-week range(U.S.) $2.35 to (U.S.) $5.59
  • Beta1.65
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$3.14
Updated January 20 4:00 PM -5GMT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-3,777.43%

AEterna Zentaris Inc has a net profit margin of -3,777.43%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX0.90%Sector:Industry:
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015
Revenue0000
Total other revenue--------
Total revenue0000
Gross profit--------
Total cost of revenue--------
Total operating expense87710
Selling / general / administrative3446
Research & development5444
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-8-7-7-10
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-6-7-4-10
Income after tax-6-7-4-10
Income tax, total--------
Net income-6-7-4-10
Total adjustments to net income--------
Net income before extra. items-6-7-4-10
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-6-7-4-10
Inc. avail. to common incl. extra. items-6-7-4-10
Diluted net income-6-7-4-10
Dilution adjustment--------
Diluted weighted average shares1010107
Diluted EPS excluding extraordinary itemsvalue per share-0.61-0.71-0.37-1.45
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.61-0.71-0.37-1.45